Skip to search.
 BSE Up 0.23% NSE Up 0.17%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
71.76 Up 1.60(2.28%) 6 Mar 2:30AM
Add to Portfolio
Prev Close:70.16
Open:70.44
Bid:71.70 x 200
Ask:72.50 x 100
1y Target Est:71.63
Beta:1.09
Earnings Date:4 May - 8 May (Est.)
Day's Range:70.25 - 72.99
52wk Range:22.25 - 75.24
Volume:3,758,783
Avg Vol (3m):3,593,730
Market Cap:8.48B
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ISIS at this time.

Comparison

Symbol% ChgMkt Cap
ISISUp 2.28%8.48B
ENZUp 0.67%135.15M
GILDUp 0.34%154.03B
SRPTUp 0.14%581.66M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.85
Quarterly EPS Est (Mar-15) :-0.23
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-3.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback